Exhibitor

King-Devick Test Inc.

King-Devick-Test

Articles published in multiple recent peer reviewed neurological journals have described the King-Devick Test as an "accurate and reliable method for identifying athletes with head trauma." Other peer reviewed recent articles have shown King-Devick Test to help determine neurological functionality in Alzheimer’s disease, Parkinson's disease, multiple sclerosis, ALS, extreme sleep deprivation, and hypoxia. In January 2015, Mayo Clinic and King-Devick Test announced a licensing agreement for the sideline concussion test. The King-Devick Concussion Screening Test is now recognized as the King-Devick Test in association with Mayo Clinic. Additionally King-Devick Test is used worldwide as a proven indicator of saccadic eye movements as they relate to reading, using Rapid Number Naming.

For more information, please visit www.kingdevicktest.com.

« Go Back

Supporting Publication
Organised by
 
  • Lancet Neurology
  • Elsevier
Silver Sponsor
 
Teva
Sponsors
 
AstraZeneca